Transition Met Chem (2010) 35:165–175
167
C–N); d 128 (aromatic, para); d 128.7 (aromatic, meta); d
129 (aromatic, ortho); d 135 (C ipso); d 141 (N–CH=N); d
149 (N–C–N); d 151 (N–C(=O)–N); d 155 (N–C(=O)–C).
HRMS (ESI): m/z calcd for C14H15N4O2Br: 271.1195
[M?–Br]; found 271.1185. FT-IR t (cm-1): 1701 (C=O),
1655 (C=O).
(aromatic, para); d 128.5 (aromatic, meta); d 129 (aro-
matic, ortho); d 135 (C ipso); d 141 (N–CH=N); d 149 (N–
C–N); d 151 (N–C(=O)–N); d 155 (N–C(=O)–C). HRMS
(ESI): m/z calcd for C15H17N4O2Br: 285.1351 [M?–Br];
found: 285.1346. FT-IR t (cm-1): 1698 (C=O), 1649
(C=O).
Characterization of 1,3-dimethyl-9,7-dibenzylxanthinium
bromide (tphBz2Br, 1a0)
trans-Dibromo bis-7-(1,3-dimethyl-9-benzylxanthine)
palladium(II) (4)
1H NMR (CDCl3, 25 °C, 400.13 MHz): d 3.40 (s, 3H,
CH3–N); d 3.58 (s, 3H, CH3–N); d 5.54 (s, 4H, PhCH2–N);
d 7.30–7.45 (m, 10H, aromatics); d 7.58 (s, 1H, C–H).
HRMS (ESI): m/z calcd for C21H21N4O2Br: 361.1664
[M?–Br]; found 361.1655.
1,3-dimethyl-9-benzylxanthinium bromide (1a, 600 mg,
1.71 mmol) was dissolved in acetonitrile (10 mL). Palla-
dium acetate (190 mg, 0.86 mmol) and sodium bromide
(176 mg, 1.71 mmol) were added, and the mixture was
refluxed for 24 h, cooled and filtered to eliminate the
excess of NaBr and any unreacted 1a. The yellow solution
1
3,7-Dimethyl-9-benzylxanthinium bromide,
or theobromineBzBr (tbrBzBr, 2a)
was evaporated to dryness. Yield: 370 mg, 54%. H NMR
(CDCl3, 25 °C, 400.13 MHz): d 3.46 (s, 1H, CH3–N); d
3.60 (s, 1H, CH3–N); d 4.57 (s, 3H, CH3–N); d 4.72 (s, 3H,
CH3–N); d 5.54 (s, 2H, PhCH2–N); d 5.57 (s, 2H, PhCH2–
N); d 7.41–7.33 (m, 10H, aromatics); d 7.91 (s, 1H, C–H);
8,00 (s, 1H, C–H). 13C{1H} NMR (CDCl3, 25 °C,
100.5 MHz): d 28.5 (CH3–N); d 30 (CH3–N); d 33 (CH3–
N); d 33.4 (CH3–N); d 51.7 (PhCH2–N); d 51.8 (PhCH2–
N); d 108.3 (O=C–C–N); d 108.4 (O=C–C–N); d 128.2; d
128.5; d 129.4; d 129.5; d 129.6 (aromatics); d 133 (C
ipso); d 133.2 (C ipso); d 140 (N–CH=N); d 146.7 (N–C–
N); d 146.9 (N–C–N); d 150.9 (N–C(=O)–N); d 151 (N–
C(=O)–N); d 153.9 (N–C(=O)–C); d 154.1 (N–C(=O)–C).
Theobromine (2, 0.50 g, 2.80 mmol) and KI (23 mg,
0.14 mmol) were suspended in benzyl bromide (5 mL) and
vigorously stirred. The mixture was refluxed for 24 h,
cooled and filtered to eliminate any unreacted xanthine and
KI. Diethyl ether (10 mL) was added and upon stirring
overnight and filtering, a brown powder was obtained.
Yield: 0.94 g, 96%. 1H NMR (DMSO-d6, 80 °C,
400.13 MHz): d 3.35 (s, 3H, CH3–N); d 3.86 (s, 3H, CH3–
N); d 5.46 (s, 2H, PhCH2–N); d 7.33–7.02 (m, 5H, aro-
matics); d 7.90 (s, 1H, C–H); d 10.72 (broad, 1H, N–H).
13C{1H} NMR (DMSO-d6, 80 °C, 100.5 MHz): d 29
(CH3–N); d 34 (CH3–N); d 50 (PhCH2–N); d 108 (O=C–
C–N); d 128.1 (aromatic, para); d 128.4 (aromatic, meta);
d 129 (aromatic, ortho); d 135 (C ipso); d 143 (N–CH=N);
d 150 (N–C–N); d 152 (N–C(=O)–N); d 155 (N–C(=O)–C).
HRMS (MALDI-FT): m/z calcd for C14H15N4O2Br:
350.0378 [M]; found 350.0435. FT-IR t (cm-1): 1685
(C=O).
trans-Dichloro bis(1,3,7-trimethyl-9-benzylxanthine-8-
ylidene) palladium(II) (6)
1,3,7-trimethyl-9-benzylxanthinium bromide (3a, 91 mg,
0.25 mmol) was suspended in THF (1.5 mL), and a solu-
tion of potassium tertbutoxide (28 mg, 0.25 mmol) in THF
(0.5 mL) was slowly added at room temperature. The
mixture was stirred at room temperature for 3 h and filtered
to eliminate KBr, and a brown solution was obtained.
PdCl2(NCPh)2 (34 mg, 0.13 mmol) dissolved in acetoni-
trile (2 mL) was slowly added to the free carbene obtained
from 3a (the brown solution), and the mixture was stirred
for 4 h at room temperature. The bright yellow solution
1,3,7-Trimethyl-9-benzylxanthinium bromide,
or caffeineBzBr (caffBzBr, 3a)
Caffeine (3, 1.00 g, 5.15 mmol) was suspended in benzyl
bromide (10 mL) and vigorously stirred. The mixture was
refluxed for 24 h and then cooled and filtered to eliminate
any unreacted 3. The solvent was reduced under vacuum,
and diethyl ether (50 mL) was added. Upon stirring for 1 h
and filtering, a pale brown powder was obtained. Yield:
1
was evaporated to dryness Yield: 160 mg, 86%. H NMR
(CDCl3,, 25 °C, 400.13 MHz): d 3.36 (s, 3H, CH3–N); d
3.55 (s, 3H, CH3–N); d 3.97 (s, 3H, CH3–N); d 5.52 (s, 2H,
PhCH2–N); d 7.37–7.35 (m, 3H, aromatics); d 7.52 (s, 1H,
aromatic, ortho); d 7.63 (s, 1H, aromatic, ortho). 13C{1H}
NMR (CDCl3, 25 °C, 100.5 MHz): d 27.5 (CH3–N); d 27.6
(CH3–N); d 29 (CH3–N); d 33 (CH3–N); d 50 (PhCH2–N);
d 107 (O=C–C–N); d 128 (aromatic, para); d 128.3 (aro-
matic, meta); d 129 (aromatic, ortho); d 135.9 (C ipso); d
136.0 (C ipso); d 141 (N–CH=N); d 141.4 (N–CH=N); d
1
0.81 g, 43%. H NMR (CDCl3, 25 °C, 400.13 MHz): d
3.39 (s, 3H, CH3–N); d 3.57 (s, 3H, CH3–N); d 3.98 (s, 3H,
CH3–N); d 5.49 (s, 2H, PhCH2–N); d 7.34–7.30 (m, 5H,
aromatics); d 7.58 (s, 1H, C–H). 13C{1H} NMR (CDCl3,
25 °C, 100.5 MHz): d 28 (CH3–N); d 30 (CH3–N); d 33
(CH3–N); d 50 (PhCH2–N); d 107 (O=C–C–N); d 128
123